Adamas Pharmaceuticals reported 8.68M in Stock for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 14.34M 3.55M
Adamas Pharmaceuticals ADMS:US 8.68M 892K
Aerie Pharmaceuticals AERI:US $ 30.06M 0.65M
Biocryst Pharmaceuticals BCRX:US $ 13.66M 3.82M
Flexion Therapeutics FLXN:US $ 14.67M 2.37M
GlaxoSmithKline GSK:LN 6244M 86M
Heron Therapeutics HRTX:US $ 41.5M 1.3M
Intra Cellular Therapies ITCI:US $ 8.17M 0.4M
Neurocrine Biosciences NBIX:US $ 25.5M 2.8M
Novartis NOVN:VX SF 6885M 226M
Omeros OMER:US $ 712K 266K
Revance Therapeutics RVNC:US $ 10.19M 5.13M
Teva Pharmaceutical TEVA:IT 4.17B 195M
Zogenix ZGNX:US $ 3.5M 0.58M